Skip to main content

Table 3 Predicted mammographic measures in women 60 and 70 years old by pattern of menopausal hormone therapy use

From: Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study

  PMD (%) DA (cm2) NDA (cm2)
Predicted (95% CI) Predicted (95% CI) Predicted (95% CI)
For women aged 60 years
 Never 24 (22 to 26) 24 (22 to 26) 78 (72 to 83)
 Current 33 (31 to 35) 33 (31 to 35) 67 (63 to 70)
 Past, 0–2 years since last use 32 (29 to 36) 33 (29 to 37) 67 (60 to 74)
 Past, > 2 years since last use 26 (24 to 29) 25 (23 to 28) 74 (68 to 81)
For women aged 70 years
 Never 20 (18 to 23) 24 (21 to 27) 94 (86 to 101)
 Current 29 (26 to 32) 33 (30 to 37) 82 (75 to 89)
 Past, 0–2 years since last use 28 (24 to 32) 33 (29 to 38) 81 (73 to 91)
 Past, > 2 years since last use 23 (20 to 26) 26 (23 to 29) 90 (82 to 98)
  1. PMD percent mammographic density, DA dense area, NDA non-dense area